Cargando…
Neurotoxic Effect of Doxorubicin Treatment on Cardiac Sympathetic Neurons
Doxorubicin (DOXO) remains amongst the most commonly used anti-cancer agents for the treatment of solid tumors, lymphomas, and leukemias. However, its clinical use is hampered by cardiotoxicity, characterized by heart failure and arrhythmias, which may require chemotherapy interruption, with devasta...
Autores principales: | Moro, Nicola, Dokshokova, Lolita, Perumal Vanaja, Induja, Prando, Valentina, Cnudde, Sophie Julie A, Di Bona, Anna, Bariani, Riccardo, Schirone, Leonardo, Bauce, Barbara, Angelini, Annalisa, Sciarretta, Sebastiano, Ghigo, Alessandra, Mongillo, Marco, Zaglia, Tania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569551/ https://www.ncbi.nlm.nih.gov/pubmed/36232393 http://dx.doi.org/10.3390/ijms231911098 |
Ejemplares similares
-
Nerve growth factor transfer from cardiomyocytes to innervating sympathetic neurons activates TrkA receptors at the neuro‐cardiac junction
por: Dokshokova, Lolita, et al.
Publicado: (2022) -
Tuning the Consonance of Microscopic Neuro-Cardiac Interactions Allows the Heart Beats to Play Countless Genres
por: Franzoso, Mauro, et al.
Publicado: (2022) -
MST1 mediates doxorubicin-induced cardiomyopathy by SIRT3 downregulation
por: Schirone, Leonardo, et al.
Publicado: (2023) -
A Light Wand to Untangle the Myocardial Cell Network
por: Zaglia, Tania, et al.
Publicado: (2019) -
Neurohumoral Cardiac Regulation: Optogenetics Gets Into the Groove
por: Scalco, Arianna, et al.
Publicado: (2021)